Ompekimig
Ompekimig is an immunoglobulin monoclonal antibody that targets IL-4, IL-13, IL-33. Ompekimig shows potential for use in immune-mediated inflammatory diseases such as asthma and atopic dermatitis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2981477-39-6
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
immunoglobulin (L-kappa-H-gamma1(_L-VH-G1(CH1-h))_L-kappa)_( H-gamma1_L-kappa)
Human
|
IL-4 |
IL-13 |
IL-33 |
Ompekimig is an antibody against hIL-4, hIL-13, and hIL-33[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Fab-kappa_IgG1-kappa_disulfide
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 2981477-39-6
-
SMILES
N/A
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ompekimig Related Classifications
HY-P991150 Related Classifications
Powered by Bioz
- Ompekimig
- 2981477-39-6
- Interleukin Related
- heavy chain amino acid sequences
- light chain amino acid sequences
- N-terminal glutaminyl cyclization
- fucosylated complex bi-antennary CHO-type N-glycosylation
- disulfide bridges
- post-translational modifications
- monoclonal antibody
- C-terminal lysine clipping
- N-terminal cyclization
- N-glycosylation
- Inhibitor
- inhibitor
- inhibit